Ligand Pharmaceuticals | LGND - Trade Debtors

Stock Price
190.44
Daily Change
-1.25 -0.65%
Monthly
-4.76%
Yearly
65.33%
Q1 Forecast
186.18

Ligand Pharmaceuticals reported $58.1M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Amgen USD 8.49B 211M Sep/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Baxter International USD 1.77B 127M Jun/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Gilead Sciences USD 5.1B 314M Sep/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Glaxosmithkline GBP 11.16B 3.46B Sep/2025
Insmed USD 65.26M 10.23M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
MacroGenics USD 69.23M 56.7M Sep/2025
Merck USD 12.12B 596M Sep/2025
Pacira USD 115.27M 901K Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Veracyte USD 47.83M 2.99M Sep/2025